152 related articles for article (PubMed ID: 34115832)
21. Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence.
Medina G; Briones-García E; Cruz-Domínguez MP; Flórez-Durante OI; Jara LJ
Autoimmun Rev; 2017 Apr; 16(4):352-354. PubMed ID: 28216071
[TBL] [Abstract][Full Text] [Related]
22. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
[TBL] [Abstract][Full Text] [Related]
24. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.
Zuily S; de Laat B; Mohamed S; Kelchtermans H; Shums Z; Albesa R; Norman GL; Lamboux-Matthieu C; Rat AC; Ninet J; Magy-Bertrand N; Pasquali JL; Lambert M; Lorcerie B; Kaminsky P; Guillemin F; Regnault V; Wahl D;
Rheumatology (Oxford); 2015 Nov; 54(11):2071-5. PubMed ID: 26163690
[TBL] [Abstract][Full Text] [Related]
25. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
26. Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis.
Meyer MF; Schnabel A; Schatz H; Gross WL
Semin Arthritis Rheum; 2001 Aug; 31(1):4-11. PubMed ID: 11503134
[TBL] [Abstract][Full Text] [Related]
27. Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study.
Broder A; Mowrey WB; Kim M; Murakhovskaya I; Billett H; Neugarten J; Costenbader KH; Putterman C
Rheumatology (Oxford); 2016 May; 55(5):817-25. PubMed ID: 26705328
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
[TBL] [Abstract][Full Text] [Related]
29. Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome.
Vreede AP; Bockenstedt PL; McCune WJ; Knight JS
Curr Opin Rheumatol; 2019 May; 31(3):231-240. PubMed ID: 30747734
[TBL] [Abstract][Full Text] [Related]
30. [Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up].
Reshetniak TM; Alekberova ZS; Kotel'nikova GP; Aleksandrova EN; Mach ES; Radenska-Lopovok SG; Kalashnikova LA; Nasonova VA
Ter Arkh; 2003; 75(5):46-51. PubMed ID: 12847898
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
32. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.
Drenkard C; Villa AR; Alarcón-Segovia D; Pérez-Vázquez ME
J Rheumatol; 1994 Jun; 21(6):1067-72. PubMed ID: 7932417
[TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M
Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863
[TBL] [Abstract][Full Text] [Related]
34. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies?
Noureldine MH; Harifi G; Berjawi A; Haydar AA; Nader M; Elnawar R; Sweid A; Al Saleh J; Khamashta MA; Uthman I
Lupus; 2016 Nov; 25(13):1397-1411. PubMed ID: 27225212
[TBL] [Abstract][Full Text] [Related]
35. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
[TBL] [Abstract][Full Text] [Related]
36. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
da Rosa GP; Sousa-Pinto B; Ferreira E; Araújo O; Barilaro G; Bettencourt P; Cervera R; Espinosa G
Arthritis Res Ther; 2022 Jan; 24(1):9. PubMed ID: 34980238
[TBL] [Abstract][Full Text] [Related]
37. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients.
Sciascia S; Radin M; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Vaccarino A; Bazzan M; Giachino O; Baldovino S; Rossi D; Mengozzi G; Roccatello D
Rheumatology (Oxford); 2021 Mar; 60(3):1106-1113. PubMed ID: 31840749
[TBL] [Abstract][Full Text] [Related]
38. Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome.
Sciascia S; Radin M; Cecchi I; Rubini E; Bazzan M; Roccatello D
Semin Arthritis Rheum; 2019 Feb; 48(4):741-744. PubMed ID: 29747993
[TBL] [Abstract][Full Text] [Related]
39. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
40. Thrombosis and thrombocytopenia in antiphospholipid syndrome: their association with mean platelet volume and hematological ratios.
Llorente-Chávez A; Martín-Nares E; Núñez-Álvarez C; Hernández-Molina G
Thromb Res; 2021 Jul; 203():12-17. PubMed ID: 33895567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
